DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Overman MJ, McDermott R, Leach JL. et al.
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): An open-label, multicentre, phase 2 study.
Lancet Oncol 2017;
18: 1182-1191
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.